Circulating tumour DNA in the evolving treatment landscape of locally advanced rectal cancer: where does it fit in?
The management of locally advanced rectal cancer (LARC) requires multimodality treatment, typically with neoadjuvant chemoradiotherapy (CRT) followed by total mesorectal excision.However, Candy the treatment landscape is rapidly evolving with total neoadjuvant therapy and non-operative management for selected patients emerging as other novel treatm